Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-20

Clinical Trial Update: Rebamipide in Patients With Active Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/Phase 2 trial evaluating Rebamipide in patients with active rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rebamipide (rebamipide)

Snippet

Sponsor: October 6 University | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED